Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Lymphoma

  Free Subscription


Articles published in J Immunol

Retrieve available abstracts of 10 articles:
HTML format
Text format



Single Articles


    June 2018
  1. HAYAKAWA K, Formica AM, Nakao Y, Ichikawa D, et al
    Early Generated B-1-Derived B Cells Have the Capacity To Progress To Become Mantle Cell Lymphoma-like Neoplasia in Aged Mice.
    J Immunol. 2018 Jun 13. pii: jimmunol.1800400. doi: 10.4049/jimmunol.1800400.
    PubMed     Text format     Abstract available


    December 2017
  2. WASIUK A, Testa J, Weidlick J, Sisson C, et al
    CD27-Mediated Regulatory T Cell Depletion and Effector T Cell Costimulation Both Contribute to Antitumor Efficacy.
    J Immunol. 2017;199:4110-4123.
    PubMed     Text format     Abstract available


    November 2017
  3. CATALAN-DIBENE J, Vazquez MI, Luu VP, Nuccio SP, et al
    Identification of IL-40, a Novel B Cell-Associated Cytokine.
    J Immunol. 2017;199:3326-3335.
    PubMed     Text format     Abstract available


    October 2017
  4. BERTOCCI B, Lecoeuche D, Sterlin D, Kuhn J, et al
    Klhl6 Deficiency Impairs Transitional B Cell Survival and Differentiation.
    J Immunol. 2017;199:2408-2420.
    PubMed     Text format     Abstract available


    April 2017
  5. LI J, Roy S, Kim YM, Li S, et al
    Id2 Collaborates with Id3 To Suppress Invariant NKT and Innate-like Tumors.
    J Immunol. 2017;198:3136-3148.
    PubMed     Text format     Abstract available


    June 2016
  6. LAPENTA C, Donati S, Spadaro F, Castaldo P, et al
    NK Cell Activation in the Antitumor Response Induced by IFN-alpha Dendritic Cells Loaded with Apoptotic Cells from Follicular Lymphoma Patients.
    J Immunol. 2016 Jun 29. pii: 1600262.
    PubMed     Text format     Abstract available


    May 2016
  7. RAJU S, Kretzmer LZ, Koues OI, Payton JE, et al
    NKG2D-NKG2D Ligand Interaction Inhibits the Outgrowth of Naturally Arising Low-Grade B Cell Lymphoma In Vivo.
    J Immunol. 2016 May 2. pii: 1501982.
    PubMed     Text format     Abstract available


    April 2016
  8. SEGAL G, Prato S, Zehn D, Mintern JD, et al
    Target Density, Not Affinity or Avidity of Antigen Recognition, Determines Adoptive T Cell Therapy Outcomes in a Mouse Lymphoma Model.
    J Immunol. 2016 Apr 1. pii: 1502187.
    PubMed     Text format     Abstract available


    January 2016
  9. WEBB LM, Datta P, Bell SE, Kitamura D, et al
    GIMAP1 Is Essential for the Survival of Naive and Activated B Cells In Vivo.
    J Immunol. 2016;196:207-16.
    PubMed     Text format     Abstract available


    September 2015
  10. VACHER P, Vacher AM, Pineau R, Latour S, et al
    Localized Store-Operated Calcium Influx Represses CD95-Dependent Apoptotic Effects of Rituximab in Non-Hodgkin B Lymphomas.
    J Immunol. 2015;195:2207-15.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: